IP Library Assignment 042876/0879
Patent Assignment
Reel/Frame 042876/0879

Assignment of Assignor's Interest

Recorded: 2017-06-16 Pages: 3
Assignor
ESUMI, HIROYASU
Executed: 2016-10-11
Assignee
TOKYO UNIVERSITY OF SCIENCE FOUNDATION
1-3, KAGURAZAKA, SHINJUKU-KU, TOKYO, 1628601, JAPAN
Covered Property (1)
Anticancer Agent and Side-Effect-Alleviating Agent
Patent: 9,907,852 →
Application: 15/302,863 →
Publication: US 2017/0028065
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 23, 2017
From: TEZUKA, YASUHIRO
To: NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMA
Reel/Frame 042466/0849 →
Assignment of Assignor's Interest Jun 16, 2017
From: YOMODA, SATOSHI; CHIBA, SHIGEKI; KAWASHIMA, TAKANORI; OKUBO, TOSHIKI
To: KRACIE PHARMA, LTD.
Reel/Frame 042736/0917 →
Assignment of Assignor's Interest Jun 16, 2017
From: IKEDA, MASAFUMI; TSUCHIHARA, KATSUYA
To: NATIONAL CANCER CENTER
Reel/Frame 042876/0876 →
Merger Jun 20, 2024
From: KRACIE PHARMA, LTD.
To: KRACIE HOLDINGS, LTD.
Reel/Frame 067794/0001 →
Change of Name Jun 20, 2024
From: KRACIE HOLDINGS, LTD.
To: KRACIE, LTD.
Reel/Frame 067794/0146 →